Firm client AbelZeta finalized a $630 million deal with AstraZeneca, obtaining complete global rights to a CAR-T cell therapy targeting liver cancer and other solid tumors.

Partners Michael Davitz and Jordan Garner were pleased to assist AbelZeta in closing this landmark transaction and supporting the development of next-generation oncology therapies.

 

 

Transaction
IP Due Diligence for Mergers, Acquisitions, and Investments
Transaction Agreements
Patent
Life Sciences
Life Sciences and Pharmaceuticals
Professionals
Tatsuya Adachi Melissa A. Alcantara Elizabeth M. Barnhard Kristin J. Breen Dexter Chang Susie S. Cheng Stacey W. Chung Lori L. Cooper* Ralph J. Crispino M. Diana Danca Michael A. Davitz Edward Ellis* Lauren B. Emerson Joel J. Felber* Matthew L. Frisbee Henry A. Gabathuler Stefanie M. Garibyan Jordan G. Garner Melvin C. Garner Vera Glonina Howard I. Grossman Sara E. Gruber Brian M. Gummow James F. Haley Mitsu Haraguchi Robert M. Isackson Marcus J. Jellen Kendra V. Johnson Cha Hyung (Catherine) Kim David Leason Michelle J. Levin Jia Li Erica S. Livingstone Karen Mangasarian Yuval H. Marcus Elyse Marcus Joshua J. Montgomery Anthony J. Natoli Cameron S. Reuber Emily A. Rice* Maha M. Saber Marlene U. Sauer Karin Segall Peter S. Sloane Audrey E. Trace* Taylor L. Vacala Yilan Wang Jarryd R. Werts
Services
Copyright Litigation Patent Trade Secret Trademark Transaction
Industries
Artificial Intelligence Computers and Technology Consumer Goods Energy Hospitality Industrials and Manufacturing Life Sciences and Pharmaceuticals Media, Arts, and Entertainment Medical Devices Professional Services Transportation and Aerospace
International
China Japan
Representative Work
Firm Accolades
Insights
All Insights News Articles The Newtonian
About
About Leason Ellis Our Approach Our Culture Pro Bono & Community Engagement
Join
Careers Why Join Us Current Opportunities
Contact